ERBB2 and gastric cancer: HER2 plays a central role in several tumors with evidence of amplification or overexpression in 7%–34% of all cancers, namely, breast, colon, bladder, ovarian, endometrial, lung, uterine cervix, head and neck, esophageal, and gastric cancers (116).